Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 24874301000001114 | Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 38069901000001115 | Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Is a | Co-zidocapt 12.5mg/25mg tablets 28 tablet | true | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Is pack of | Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) | false | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available | true | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Has active ingredient | Captopril | false | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Has excipient | Lactose | false | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Discontinued indicator | Never discontinued | false | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Legal category | Prescription only medicine - legal category (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Has AMP | Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) | true | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Has specific active ingredient | Hydrochlorothiazide | true | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Has specific active ingredient | Captopril | true | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Is a | Actual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | Discontinued indicator | Discontinued AMPP(qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Capozide LS 12.5mg/25mg tablets (Bristol-Myers Squibb Pharmaceuticals Limited) 28 tablet 2 x 14 tablets | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR